MedTrace Logo

An Ascending Dose Study of PIT565 in Participants With Rheumatoid Arthritis

NCT07029555 · Status: RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 57

Last updated 2026-05-01

No results posted yet for this study

Summary

The purpose of the study is to determine the safety, tolerability, and pharmacokinetics of PIT565, in participants with rheumatoid arthritis (RA).

Conditions

Interventions

BIOLOGICAL

PIT565

Study treatment will be provided in vials as open-label participant specific supply.

Sponsors & Collaborators

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-12
Primary Completion
2028-05-15
Completion
2028-05-16

Countries

  • Argentina
  • Bulgaria
  • China
  • France
  • Germany
  • Hungary
  • Netherlands
  • Romania
  • Spain

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07029555 on ClinicalTrials.gov